Peptide Solutions Appointed as Distributor
for Iris Biotech for all North American Sales

We at Iris Biotech, are pleased to announce that we have entered into an agreement with Peptide Solutions, LLC to sell the complete line of our products in the USA and Canada.

Peptide Solutions
3280 E Hemisphere Loop, Suite 184, Tucson, AZ 85706 USA
Phone (520) 392-8792 ● Fax: (520) 422-2003
Email: sales@easypeptide.com ● Web: www.easypeptide.com

Peptide Solutions’website has a link to our complete list of products so ordering online is extremely easy, however, personal contact is available at the phone listed above, Monday through Friday, 8am to 5pm MST

Benefits from our partnership for you:

• Personal skilled contact
• No issues with customs or tax
• Dramatically reduced transport charges
• Consumables on stock in USA -> fast deliveries for your project
• Simple and easy domestic business processing
• Always the possibility to get further assistance from the team of Iris Biotech

Consumable for peptide synthesis for affordable prices or
Unusual compounds for sophisticated peptidomimetics and drug discovery You get it all from us.

Our mission is our promise:
“we accompany you and your project from R&D through to production”
Lab scale for research – kg’s for pilot scale – ton lots for commercial production
Everything from one hand.

“With Peptide Solutions, we found a North American partner with vast knowledge of the academic, pharma, and biotech markets in the USA and Canada. We believe it is in the best interest of our USA and Canadian clients to have fast and direct access to our products and services and this is exactly what this new partnership will create.”
Oskar Tropitzsch, CEO of Iris Biotech GmbH

“We, at Peptide Solutions, could not be happier with our new partnership with Iris Biotech. We consider the addition of the full line of Iris Biotech products to our current offering as a positive for both us as well as the North American customers of Iris. We promise to give full and complete service to the customers of Iris in both the USA and Canada.”
Mahendra Menakuru, President and CEO of Peptide Solutions, LLC